long intergenic non-protein coding RNA 2185Genealiases: []
Q-omics provides the consensus-scored LINC02185 profile across patient tissues and cancer cell-line models. LINC02185 expression is associated with patient survival in 21 of 34 cancer types, with the highest sampling consensus in UCEC. Among the 18 cancer types available for tumor–normal comparison, LINC02185 is differentially expressed in 13, with the highest sampling consensus in COAD. Additionally, LINC02185 RNA expression shows 16,596 significant gene co-expression associations, with the highest sampling consensus in UVM. Together, these results highlight UCEC, COAD, and UVM as cancer lineages where LINC02185 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for LINC02185 — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes LINC02185 survival associations across molecular data types. LINC02185 RNA expression shows survival associations in the most cancer types (21). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible LINC02185 RNA expression–survival associations across cancer types. High LINC02185 expression shows unfavorable associations in UCEC, UVM and KIRP, but favorable associations in SKCM, ACC and HNSC. The UCEC Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p < 0.001). Together, the overview and detailed table identify UCEC as the clearest survival context for LINC02185 RNA expression.
This table summarizes LINC02185 tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 13. The strongest signals are observed in COAD for RNA.
This table ranks reproducible tumor–normal expression differences for LINC02185. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. LINC02185 shows lower tumor expression in COAD, BLCA, THCA, LUAD and LUSC and higher tumor expression in LIHC. The COAD box plot shows higher LINC02185 RNA expression in normal versus tumor tissue (log2 FC = −0.562, t-test p < 0.001).
This table shows molecular features associated with LINC02185 in patient tissues and cancer cell lines. In patient samples, LINC02185 shows the broadest associations at the RNA and protein expression levels, with UVM recurring as the lineage with the largest associated feature set.
